Blood thickening cases: European Authority declares AstraZeneca vaccine safe

The European Medicines Agency (EMA) has stated that the AstraZeneca vaccine is safe and effective, despite concerns about its potential side effects. 

The announcement was made on March 18, after several countries in Europe temporarily suspended the use of the AstraZeneca vaccine after nearly 30 cases of blood clots or blood clots.

The EMA said the benefits of the vaccine far outweighed the potential risks and that the agency had not identified problems with the vaccine shipment or its quality.

However, the European Union has said it is unable to say for sure whether the vaccine has anything to do with blood clots.

European nations resume use of AstraZeneca Covid vaccine after regulator signs off

"This is a safe and effective vaccine," said Emmer Cookie, EMA's executive director, during a press briefing.

"The benefits of the vaccine outweigh its potential risks in protecting people from cod, hospitalization, and death," he said. The committee also concluded that the vaccine does not increase the overall risk of blood clots. We cannot rule out a link between cases and vaccines.

The EMA said it would continue to investigate possible links between blood clots and the vaccine while updating vaccine guidelines to clarify potential risks.

The EMA statement said that 20 million people in the UK and the European Union had been vaccinated by March 16, during which time only 7 cases of blood clots and 18 cases of platelet deficiency were reported, which had nothing to do with the vaccine. Not yet proven, but it is possible and requires further analysis.

The first reports of blood clots in people using the AstraZeneca vaccine came from Austria, which caused a wave of concern, and vaccination of a specific consignment of vaccines was stopped there.

Following Austria, the vaccine was temporarily suspended last week in Austria, Denmark, Norway, and Iceland, and on March 14 by the Netherlands and Ireland.

On March 15, the three largest EU countries, France, Germany, and Italy, as well as Spain, Latvia, and Slovenia suspended AstraZeneca vaccinations due to these concerns, while on March 16, Sweden and Luxembourg also joined the list.

The World Health Organization (WHO) said on March 17 that vaccinations to prevent code 19 do not reduce the risk of disease or death from other causes, and that platelet loss is quite common.

"The benefits of vaccines outweigh the potential risks, and we recommend that vaccinations continue," the WHO added.

For more details click here.